SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,249.39 -460.30
( -0.62%)

Global Indices

Nasdaq

52,880.09 363.21
(0.69%)

Dow Jones

7,780.08 46.51
(0.60%)

Hang Seng

63,134.14 -1,487.10
(-2.30%)

Nikkei 225

10,723.99 -28.89
(-0.27%)

Forex

USD-INR

94.82 -0.08
(-0.09%)

EUR-INR

106.45 0.01
(0.01%)

GBP-INR

126.63 0.25
(0.20%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

131.5

418683.95

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.92

Back

Homre consolidated net profit rises 270.59% in the June 2026 quarter

Jul 24,2026

Net profit of Homre rose 270.59% to Rs 0.63 crore in the quarter ended June 2026 as against Rs 0.17 crore during the previous quarter ended June 2025. Sales reported to Rs 11.92 crore in the quarter ended June 2026. There were no Sales reported during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	11.92	0	0
OPM %	3.19	0	-
PBDT	0.85	0.23	270
PBT	0.85	0.23	270
NP	0.63	0.17	271

73,249.39 -460.30 ( -0.62%)

52,880.09 363.21 (0.69%)

7,780.08 46.51 (0.60%)

63,134.14 -1,487.10 (-2.30%)

10,723.99 -28.89 (-0.27%)

94.82 -0.08 (-0.09%)

106.45 0.01 (0.01%)

126.63 0.25 (0.20%)

0.60 0.00 (-0.04%)